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Abstract
Purpose – The European Union recommendations for patient safety calls for shared clinical risk
management (CRM) safety standards able to guide organizations in CRM implementation. The purpose
of this paper is to develop a self-evaluation tool to measure healthcare organization performance on
CRM and guide improvements over time.
Design/methodology/approach – A multi-step approach was implemented including: a
systematic literature review; consensus meetings with an expert panel from eight Italian leader
organizations to get to an agreement on the first version; field testing to test instrument feasibility
and flexibility; Delphi strategy with a second expert panel for content validation and balanced
scoring system development.
Findings – The self-assessment tool – Clinical Assessment of Risk Management: an INtegrated
Approach includes seven areas (governance, communication, knowledge and skills, safe environment,
care processes, adverse event management, learning from experience) and 52 standards. Each
standard is evaluated according to four performance levels: minimum; monitoring; outcomes; and
improvement actions, which resulted in a feasible, flexible and valid instrument to be used throughout
different organizations.
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Practical implications – This tool allows practitioners to assess their CRM activities compared to
minimum levels, monitor performance, benchmarking with other institutions and spreading results to
different stakeholders.
Originality/value – The multi-step approach allowed us to identify core minimum CRM levels in a
field where no consensus has been reached. Most standards may be easily adopted in other countries.
Keywords Benchmarking, Clinical governance, Patient safety, Risk management, Self-assessment,
Clinical risk management
Paper type Research paper
Introduction
Clinical risk management (CRM) is a key clinical governance component, defined by
Scally and Donaldson (1998, p. 62) as:
A system through which organisations are accountable for continuously improving the
quality of their services and safeguarding high standards of care, by creating an environment
in which excellence in clinical care will flourish.
According to a shift from person to organization CRM responsibility, a failure in
patient safety must be approached as a system gap resulting from interacting
variables rather than a gap in a single individual performance. Healthcare staff are
therefore expected to make patient safety a priority by introducing strategies and
measures to identify eventual systems failures before an adverse event (AE) may
occur and minimize/control healthcare risks (Øvretveit, 2005). Moreover, making
patient safety a priority for healthcare managers is increasingly supported by studies
demonstrating that specific safety interventions are cost-effective (Møller et al., 2012)
and that quality improvement makes care better for patients and saves money in
many situations (Øvretveit, 2009). Systematically implementing a patient safety
approach within the organizations is also emphasized by the council of Europe’s 2009
recommendations where, in addition to focussing attention on clinical risk and
healthcare associated infections issues, European Union (EU) health managers were
asked to adopt precise actions for general patient safety. It is estimated that between
8 and 12 percent of EU inpatients are AE victims and member states were asked to
make clear their CRM actions and their impact on patient safety by 2012 (The Council
of the European Union, 2009).
In Italy, the patient safety theme has been addressed at various levels. At national
(macro) level, Ministry of Health staff promoted many initiatives to promote patient
safety, raise awareness and train operators and patients on clinical risk and its
management. Specific CRM programs and organizational models have been
implemented in many regions (meso level). Despite all these efforts, at the
organization micro level (hospitals, local health authorities (LHAs)), implementing
adequate patient safety programs still suffer from wide variability (Tartaglia
et al., 2007).
In this context, minimum required levels that are sustainable and consistent with the
evidence and with European, national and regional recommendations (Italian Ministry of
Health, 2007; Vincent, 2010; Marx, 2001), may represent the baseline for an effective
patient safety approach inside healthcare organizations. At the same time, identifying
indicators to measure each healthcare institution’s performance on these standards may:
allow managers to analyze and monitor their performance over time; promote
benchmarking; foster exchanging best practices and also support transparent information
flow on system evolution to stakeholders (Merle et al., 2009). Furthermore, standards
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measurement and performances evaluation identify the key healthcare quality
improvement elements (Institute of Medicine, 2011; Swensen et al., 2010). Our main aim,
therefore, was to assemble standards and measurable elements that allow healthcare
managers to evaluate CRM performance and guide sustainable safe practice.
Design
The self-evaluation tool was developed by a CRM expert panel coming from eight
Italian organizations, followed by a field testing and a validation phase by a second
external expert panel (using a Delphi technique). Specifically, the development process
followed six steps:
(1) a systematic literature review on CRM evidence and best practices (updated
regularly during the project’s two-year life);
(2) expert panel evaluation to get an agreement on the instrument’s preliminary
version (consensus meetings);
(3) two pilot studies to test instrument feasibility and flexibility (field testing);
(4) updating the instrument after field testing (consensus meetings);
(5) a validation phase applying the Delphi process with a second independent
expert panel not involved in the development process to finalize the
instrument; and
(6) developing a balanced scoring system for minimum required levels.
Literature review and consensus meetings
To ensure the instrument was developed according to the best available evidence, two
methods were used and integrated for the preliminary version: a literature review and
an expert panel evaluation. A systematic literature review was performed using the
following keywords and MeSH terms: risk assessment; quality improvement; risk
management; patient safety; performance improvement; frameworks; safety indicators;
self-assessment tools and safe practice. CRM, patient safety, quality management and
improvement publications, along with international accreditation manuals and
self-evaluation tools on specific safety themes (e.g. hand hygiene, infection control)
have been included. While the literature review was primarily used for building tool
content, two main approaches were considered pivotal for tool development: the French
Government’s Indicateur Composite des Activités de Lutte contre les Infections
(ICALIN) (French Ministry of Health, 2004) and WHO’s Hand Hygiene Self-Assessment
Framework (World Health Organization, 2010).
The ICALIN framework was used as a model for building the standards
progression, translating its original logical sequence, organization-moyens-actions
(organization-means-actions), into organizational setup-activity monitoring-outcomes-
improvement actions sequence that was developed for each standard. The WHO’s
framework was used as a model for a self-assessment tool to highlight existing
achievements and focus on future plans and challenges, identifying issues requiring
improvement. At the same time, experts needed to develop a tool to compare
organizations of different sizes and complexity, and suitable for being used as an
institutional monitoring tool, overcoming two limitations. Results from the systematic
review were elicited and tabulated in a preliminary instrument. Specifically, main
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priority areas for a CRM approach were identified together with main key elements
(standards) for each area. Experts were then asked to express their opinion on the tool’s
appropriateness and completeness:
(1) Which are the main priority areas for an effective CRM approach able to create
and maintain safe care, reduce AEs and improve human performance?
(2) What are the standards for evaluating such a CRM program?
(3) Which objective measures (indicators) can be implemented to evaluate
standards implementation?
The panel met every four months for two years to get an agreement. After each
meeting, the instrument was updated. The process was repeated until all standards/
indicators were covered and no further improvements were deemed necessary.
Field testing and revision
Two pilot studies were carried out with different purposes. The first was testing
indicator feasibility and calibrating minimum levels. The second was testing tool
flexibility when applied in different healthcare institutions. Each leader organization
recruited two satellite organizations from LHAs, residential care facilities (RCFs) and
hospitals, creating two opportunistic samples (12 healthcare institutions each). The first
pilot study was carried out in 12 hospitals, where local risk managers and other
personnel involved in patient safety or quality management tested the first version.
To collect eventual critical issues on item interpretation, clarity, response format and other
feasibility issues, feedback was systematically collected during tool administration by
two researchers. Field testing results, along with suggestions and advices from risk
managers, were discussed by expert panel members and used for tool revision (e.g. item
reformulation/explanation). The second pilot study was carried out in 12 other
organizations (four LHAs, four RCFs and four hospitals), where the updated tool was
tested by local risk managers. Specifically, each standard was translated on a four-
point scale (0 – no implementation; 1 – organizational setup; 2 – activity monitoring;
3 – outcomes measurement; 4 – improvement actions) and average scores were
calculated for each standard and area with institution type as the analysis unit. Second,
testing results were discussed by expert panel members and used to develop the final
version. Specifically, standards with the lower scores were reviewed to identify
indicators not applicable for some institutions and the tool was modified accordingly.
In this phase, having improvement actions implemented for each standard was deemed
an unrealistic target and an excessive burden for users; therefore, improvement actions
were taken out from single standards and considered relevant at area level.
Validation and scoring system: Delphi technique
To validate the final tool and develop an appropriate scoring system, a second external
expert panel, not involved in the development process, was recruited to use the Delphi
technique – a structured process designed to collect expert opinions on a specific field
(Black et al., 1999; Jones and Hunter, 1995; Philips et al., 2004). For the new panel, 17
national and international experts were enrolled (three medical directors, nine clinical
risk managers working in local health units or university hospitals, one healthcare
worker specializing in CRM and three patient organization representatives). The
project’s aim and the methodological features were explained in detail to the reviewers
and consensus was collected. Experts were then asked to evaluate the instrument’s
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relevancy, clarity, appropriateness and representativeness. Content-related construct
validity was gathered for the validation process. According to the method, the peer-
review process was organized in several rounds and characterized by the following
elements:
• Selected reviewers’ anonymous and critical contributions. Reviewers did not
interact with project members or between each other.
• Preserving reviewer confidentiality and identity.
Panel feedback was managed electronically. Potential issues related to interactions
among the reviewers, or between reviewers and project members were avoided. Gaps
or shortcomings detected by the panel were systematically collected with proposed
practical solutions and revisions to improve the assessment tool’s diagnostic
sensitivity. After each Delphi round, the tool was updated and independently shown to
each panel member for a new peer-review round. When agreement was reached on the
final tool, a balanced scoring system was developed for minimum levels. Experts were
asked to rank each item’s importance/relevance and a minimum level on a ten-point
Likert scale. Mean scores were calculated for each standard to identify main priority
areas. The weight was defined according to the mean value derived using expert
scores. Every section was characterized by summary scores for which an interpretation
was provided. Results were used to develop a weighted score attributed to each
minimum level. Variables were analyzed descriptively to describe qualitative variable
frequency. Means and standard deviations were computed to assess central tendency.
Statistical analyses were carried out using Stata 9.0 (StataCorp, Stata Statistical
Software Release 9, College Station, TX, USA, 2005).
Findings
Tool – final version
The final self-assessment tool, named Clinical Assessment of Risk Management: an
INtegrated Approach (CARMINA), includes 52 standards, distributed in seven areas:
(1) governance, awareness and measurement (seven standards);
(2) communication (five);
(3) knowledge and skills (five);
(4) safe work context and environment (13);
(5) care processes (14 standards);
(6) AE management (four); and
(7) learning from experience (four).
Each standard is evaluated according to objective criteria (indicators) framed as
questions with yes/no answers. For each standard, indicators have been selected to
reflect CRM implementation levels according to the following aspects:
(1) organizational/functional setup;
(2) activity monitoring;
(3) outcomes; and
(4) improvement actions.
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The first level (organizational/functional setup) measures whether the standard is
active in the organization. The second level aims to measure whether and how activity
is monitored, while the third level evaluates whether outcomes were achieved,
systematically collected and spread within the whole organization. Lastly, the fourth
level (implementing improvement actions) is considered transversal across the areas
2-5 and it is measured as a separate standard at the end (Figure 1); the remaining areas
are not associated with improvement actions as they cover core risk management
aspects (area 1) and tools (areas 6 and 7).
The minimum required level (Table I) is set on organizational/functional setup level
for every standard and on at least one improvement action for areas. This final version
was developed after several drafts elaborated throughout two years.
Results from the first field testing and second expert group evaluation allowed
specific content and format improvements. Results from the second field testing are
shown in Table II. Mean scores for hospitals (3.38 – SD: 1.17) and LHAs (3.12 – SD: 1.25)
are significantly higher ( po0.05) than RCFs (1.63 – SD: 1.64) for most areas and for the
total score.
Scoring system
According to the balanced scoring system developed through the Delphi technique, each
minimum level’s implementation leads to a weighted score. Summing leads to the highest
score obtained for each area. Range scores were identified within each area to obtain
compliance with the standard from major gaps absent (higher scores), gaps demanding
attention (intermediate scores) and major gaps present (lowest scores) (Table III).
Moreover, as the tool was designed to be used in a hospital/healthcare institution, some
differences on standards implementation between different facilities or single care units
(CUs) are expected. To develop a scoring system able to take into account these possible
different implementation levels, a diffusion table was included where pertinent.
Description of the
standard
Standard 4.5: The organization defines and monitors the various steps
in the processes concerning the management of specimens containing
biological material
Objective criteria Self
evaluation
1 - Organizational
setup (Minimum
required level)
The organization defines in writing how to manage
specimens containing biological material (including
storage, mismatch prevention, identification)
Yes No
2 - Activity
Monitoring
The organization monitors the various steps in the
processes
Yes No
3 - Outcomes
The organization communicates the results achieved
organization-wide in the report referred to under
Standard 1.3
Yes No
4 - Improvement
Actions
In the past year, the organization implemented at least
one new improvement action concerning the standards
listed under area 4. Safe environment and context
Yes No Figure 1.
Standards –
structure (example)
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Area 1: governance, awareness and measurement
1.1: organizational strategy In the organizationa, the clinical risk management
strategy is organized as established in a defined,
approved document, and all relevant
responsibilities are identified
1.2: resources invested The organization sets yearly clinical risk
management goals
1.3: report The organization draws up and distributes at least
one yearly report on the clinical risk management
results achieved
1.4: adverse events The organization uses a defined process to collect
adverse/near-miss events reports
1.5: monitoring system The organization has in place monitoring systems
for specific adverse events
1.6: information The organization has a specific formal document
describing how it informs citizens/patients about
clinical risks
1.7: benchmarking In the past two years, the organization adopted
defined comparative programs
Area 2: communication
2.1: communication with healthcare provider The organization has formally adopted an internal
communication system
2.2: communication between healthcare
providers at admission/discharge/transfer
The organization has a policy for managing
communication concerning admissions/discharges/
transfers from the healthcare organization
2.3: communication between healthcare
providers during hospitalization
The organization uses an integrated and
uniform medical record which accompanies
the patient
2.4: safety information to patient The organization has defined and documented
informative material for every care unit (in addition
to informed consent) concerning at least one of the
most significant patient safety risks
Improvement Area 2 In the past year, the organization implemented at
least one new improvement action concerning the
standards listed under Area 2: communication
Area 3: knowldege and skills
3.1: physician’s clinical care duties The organization uses a defined process system to
assign job descriptions to its clinical staff and
leaders
3.2: other healthcare provider’s clinical care
duties
The organization has a defined process to assign job
descriptions to its healthcare staff
3.3: ongoing training In the past 12 months, the organization offered
training on patient safety-related topics
3.4: training newly employed The organization has a plan to provide newly
employed staff with well-defined training on clinical
risk management, within the first year of
employment
Improvement Area 3 In the past year, the organization implemented
at least one new improvement action concerning
the standards listed under Area 3: knowledge
and skills
(continued )
Table I.
Minimum required
levels
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Area 4: safe environment and context
4.1: integration of functions The organization has a defined model to integrate
different hospital functions
4.2: non-compliance in maintenance plans At least once a year, the organization checks all non-
conformities resulting from the ordinary/
extraordinary maintenance activities performed in
the facilities, utilities and equipment
4.3: medications pathway The organization defines in writing how to obtain,
store, prepare and dispense medications
4.4: medical devices pathway The organization defines in writing how to obtain
(and perform risk analyses on) medical equipment
4.5: biological specimen pathway The organization defines in writing how to manage
specimens containing biological material (including
storage, mismatch prevention, identification)
4.6: food pathway The organization defines in writing the food
management processes
4.7: sterilization pathway The organization defines in writing the sterilization
processes
4.8: waste pathway The organization defines in writing the waste
management process
4.9: transportation safety The organization defines in writing how patients
are to be transported inside the organization (and to/
from other external organizations) and provides
written instructions concerning the safety
standards for such patients
4.10: structural internal emergencies The organization has plans instructing on how to
deal with internal structural emergency situations
4.11: external maxi-emergencies The organization has plans instructing on how to
deal with major external emergencies
4.12: recall procedures The organization adopts procedures to recall
products, medications, and medical devices,
according to a defined schedule and involving both
health practitioners and patients
Improvement Area 4 In the past year, the organization implemented at least
one new improvement action concerning the standards
listed under Area 4: safe environment and context
Area 5: care processes
5.1: double identifier The organization has a procedure requiring the use
of two identifiers for all patients receiving care,
treatment, or other procedures
5.2: read-back The organization has a procedure to check if the
order or report made by the sender was understood
by the receiver
5.3: management of falls The organization has a procedure on how to
manage the risk of patient falls (including the use of
a risk assessment scale)
5.4: decubitus ulcers The organization has a procedure that is shared by
all the care providers concerned, to manage the risk
of decubitus ulcers (including the use of a risk
assessment scale)
5.5: hand hygiene The organization has a procedure on hand hygiene
that is based on the WHO hand hygiene guidelines
(continued ) Table I.
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5.6: standard/isolation precautions The organization has a procedure on the isolation of
patients with infective diseases
5.7: healthcare-associated infections The organization has a procedure (shared by the
HAICCb and the operative group) on the prevention,
surveillance and control of healthcare-associated
infections
5.8: pain management The organization has a procedure on pain
management (which includes adopting an
assessment scale, performing an initial assessment
and re-assessing pain periodically)
5.9: internal care-related emergencies The organization has a procedure on internal
healthcare emergencies
5.10: safety in the operating theater The organization has a procedure on operating
theater safety, and such procedure is based on the
goals set forth in the Ministerial Guidebook
5.11: clinical-care pathways The organization has in place 1-3 care pathways
(with defined schedules, persons involved, and
responsibilities)
5.12: maternal and newborn pathway The organization defines in writing the pregnancy
and childbirth clinical pathways, based on the
estimated risk
5.13: ministerial recommendations The organization applies the ministerial
recommendations on patient safety
Improvement Area 5 In the past year, the organization implemented at
least one new improvement action concerning the
standards listed under Area 5: care processes
Area 6: adverse event management
6.1: immediate and medium-term management
of adverse events
The organization adopts defined methods to manage
immediate and medium-term operational issues after
the occurrence of an adverse or near miss event
6.2: communication with patients, family or
relatives, media, and internal
The organization adopts a defined communication
method to manage the adverse event vis-à-vis
patients and family members
6.3: communication with institutions and/or
associations
The organization adopts a defined method to support/
assist staff involved in the adverse event, in the
appropriate setting and in a non-punitive atmosphere
6.4: support/assistance to healthcare providers The organization adopts a defined method to
support/assist patient/family members involved in
the adverse event
Area 7: learning from experience
7.1: RCA In the past year the organization conducted at least
1 response analysis using consolidated techniques
to investigate adverse and near miss events
7.2: HFMEA/FMEA/FMECA In the past two years, the organization conducted at
least 1 proactive analysis using the HFMEA/
FMEA/FMECA technique
7.3: safety culture In the past three years, the organization conducted
at least one survey (qualitative/quantitative/semi-
quantitative) on the culture of safety among
healthcare workers
7.4: peer assessment In the past year, the organization carried out from 1
to 3 safety-oriented peer assessment activities
Notes: aThe term organization refers to organization’s legal representative; bhealthcare associated
infection control committeeTable I.
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This table (Figure 2) works as a score modifier: full score when W75 percent of CU staff
implement the standard, three quarters when the percentage is between 50 and 75, half
the score for a percentage between 50 and 25 percent and finally a quarter when the
standard was implemented in less than 25 percent of the units.
A total score for the whole questionnaire was than developed. However, to calculate
the total score, institutions need to reach the highest score range (major gaps absent) in
each area. Whether in one or more areas, the score indicates gaps needing further
improvements or major gaps, institution managers are encouraged to work on these gaps
before getting to a comprehensive self-evaluation. Once major gaps are excluded for each
area (minimum required levels implemented), the final total score can be calculated. Total
score divided into three range scores from minimum required levels achieved (maximum
total score achieved, total score¼ 877, space for further improvements (total score
between 780 and 876) and major gaps absent, improvement needed (total scoreo780).
Practical implications
Tool development method
The multi-step study design (literature review, consensus meeting, field testing and
Delphi technique) was developed to gain higher content validity in a field suffering
from no widely accepted and reliable assessment tools. The literature review offered
the opportunity to start tool development from best evidence, whereas involving
healthcare professionals at different levels (first round experts, feedback from
healthcare professionals testing the instrument in their organizations and second round
external experts panel) allowed us to integrate several viewpoints and experiences.
This strategy allowed us to collect all relevant information from all existing sources
and systematically organize them in a feasible and reliable instrument. Using a second
expert panel (not involved in the developmental process) allowed us to ensure that all
additional necessary improvements are taken into account, which helped to further
refine the instrument after stakeholder contributions. Moreover, the Delphi technique
avoided face-to-face interactions, overcoming limitations related to group discussions
(personal conflicts, hierarchy issues limitation free opinion exchange, leadership
influence) while preserving groups interactions advantages (experience and knowledge
exchange, creative synthesis, integration, etc.). These characteristics makes Delphi a
reliable strategy for content validation when there is no gold standard. The scoring
system for minimum required levels was balanced according to main priorities areas
(based on expert opinion) and to standards implementation within the organization.
Total scores for area and whole assessment allow us to get a rapid and clear picture on
CRM implementation. Synthetic scoring ranges represent verification and comparison
within the organization or with other organizations; the final goal is promoting a
gradual improvement, action list and programs.
Area 1 Area 2 Area 3 Area 4 Area 5 Area 6 Area 7 Total
Hospitals 3.64 (1.21) 4.00 (0.00) 3.00 (1.41) 3.38 (1.01) 3.54 (0.90) 2.40 (1.72) 3.38 (1.41) 3.38 (1.17)
LHA 3.57 (1.16) 3.75 (0.58) 3.19 (1.11) 3.25 (0.98) 2.88 (1.40) 2.80 (1.20) 2.56 (1.82) 3.12 (1.25)
RCF 0.73 (1.42) 3.38 (1.19) 2.25 (1.75) 1.86 (1.55) 1.91 (1.51) 0.40 (1.01) 0.50 (1.41) 1.63 (1.64)
Total 2.89 (1.73) 3.72 (0.73) 2.91 (1.38) 2.95 (1.25) 2.82 (1.42) 2.03 (1.60) 2.25 (1.92) 2.82 (1.49)
p-value o0.05 0.329 0.420 o0.05 o0.05 o0.05 o0.05 o0.05
Notes: 0¼ standard not implemented; 1¼ setup; 2¼monitoring; 3¼ outcomes; 4¼ improvement
Table II.
Compliance during
second field
testing (n¼ 12):
mean scores (SD)
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Standard Average ± SD Score
Area 1: governance, awareness and measurement
1.1: organizational strategy 9.5± 0.9 19
1.2: resources invested 8.9± 1.4 18
1.3: report 8.5± 1.3 17
1.4: adverse events 8.8± 1.4 18
1.5: monitoring system 8.6± 1.2 17
1.6: information 7.3± 2.1 15
1.7: benchmarking 7.6± 2.0 15
Maximum score 119
Absence of major gaps W104
Presence of gaps demanding attention 89-104
Presence of major gaps o89
Area 2: communication
2.1: communication with healthcare provider 8.5± 1.5 17
2.2: communication between healthcare providers at admission/
discharge /transfer 8.1± 1.8 16
2.3: communication between healthcare providers during hospitalization 9.1± 1.2 18
2.4: safety information to patient 8.3± 1.8 17
Improvement actions Area 2 8.0± 1.5 16
Maximum score 84
Absence of major gaps W69
Presence of gaps demanding attention 54-69
Presence of major gaps o54
Area 3: knowledge and skills
3.1: physician’s clinical care duties 7.2± 2.3 14
3.2: other healthcare provider’s clinical care duties 7.8± 1.8 16
3.3: ongoing training 9.3± 1.3 19
3.4: training newly employed 8.7± 1.5 17
Improvement actions Area 3 7.5± 2.0 15
Maximum score 81
Absence of major gaps W66
Presence of gaps demanding attention 51-66
Presence of major gaps o51
Area 4: safe environment and context
4.1: integration of functions 8.2± 2.1 16
4.2: non-compliance in maintenance plans 8.2± 1.5 16
4.3: medications pathway 8.5± 1.3 17
4.4: medical devices pathway 8.1± 1.6 16
4.5: biological specimen pathway 8.5± 1.7 17
4.6: food pathway 8.0± 1.8 16
4.7: sterilization pathway 9.2± 1.1 18
4.8: waste pathway 8.2± 2.0 16
4.9: transportation safety 7.8± 1.5 16
4.10: structural internal emergencies 8.3± 1.7 17
4.11: external maxi-emergencies 8.3± 2.0 17
4.12: recall procedures 8.4± 1.8 17
Improvement actions Area 4 7.8± 1.8 16
Maximum score 215
Absence of major gaps W200
Presence of gaps demanding attention 185-200
Presence of major gaps o185
(continued )
Table III.
Weighted scores
developed using the
Delphi technique
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Standard Average ± SD Score
Area 5: care processes
5.1: double identifier 9.0± 1.4 18
5.2: read-back 7.9± 2.1 16
5.3: management of falls 9.2± 1.3 18
5.4: decubitus ulcers 9.2± 1.1 18
5.5: hand hygiene 9.0± 1.1 18
5.6: standard/isolation precautions 8.7± 1.5 17
5.7: healthcare-associated infections 9.3± 1.3 19
5.8: pain management 8.9± 1.1 18
5.9: internal care-related emergencies 9.0± 1.2 18
5.10: safety in the operating theater 9.7± 0.6 19
5.11: clinical-care pathways 8.2± 1.0 16
5.12: maternal and newborn pathway 8.6± 1.3 17
5.13: ministerial recommendations 9.1± 1.4 18
Improvement actions Area 5 8.3± 2.1 17
Maximum score 247
Absence of major gaps W232
Presence of gaps demanding attention 217-232
Presence of major gaps o217
Area 6: adverse events management
6.1: immediate and medium-term management of adverse events 8.8± 1.7 18
6.2: communication with patients, family or relatives, media, and internal 8.5± 1.5 17
6.3: communication with institutions and/or associations 8.4± 1.5 17
6.4: support/assistance to healthcare providers 8.5± 1.3 17
Maximum score 69
Absence of major gaps W54
Presence of gaps demanding attention 39-54
Presence of major gaps o39
Area 7: learning from experience
7.1: RCA 8.2± 2.1 16
7.2: HFMEA/FMEA/FMECA 7.5± 2.1 15
7.3: safety culture 7.7± 1.8 15
7.4: peer assessment 8.2± 1.7 16
Maximum score 62
Absence of major gaps W47
Presence of gaps demanding attention 32-47
Presence of major gaps o32
Total score
Minimum required level achieved 877
Space for further improvement 780-876
Absence of major gaps, improvement needed o780 Table III.
CARE UNITS (CUs)
>75% of CUs meet the standard
51 to 75% of CUs meet the standard
25 to 50% of CUs meet the standard
<25% of CUs meet the standard
Figure 2.
Diffusion
755
Assessment
of Risk
Management
D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
TA
 D
EG
LI
 S
TU
D
I D
I V
ER
O
N
A
 A
t 0
5:
55
 2
5 
A
ug
us
t 2
01
6 
(P
T)
Tool benefits
CARMINA can be useful at three levels:
(1) As it was conceived as a standards system, CARMINA can be used as a CRM
monitoring instrument at national level, allowing the government to know where
minimum levels were achieved – a starting point for reducing unevenness among
healthcare organizations (directly at micro level) and also a possibility for a more
persuasive strategy for CRM implementation through mandatory minimum
level achievement.
(2) As a benchmark system, CARMINA makes staff compare orgiansiations,
helping them to recognize strengths and weaknesses, and highlighting areas
where interventions are more urgent. Comparing performance in similar
institutions can also to identify and share good practices.
(3) As an improvement tool, using the questionnaire regularly helps managers
track actions and progresses, helping to address efforts on weaker areas.
The tool has been developed for maximum flexibility and the second pilot study results
are encouraging in that sense. Different realities (hospitals, LHAs, RCFs) are reflected
in the results: hospitals and LHAs are almost at the improvement stage (4th level),
while RCFs are between setup and monitoring (first and second level). Taking a careful
look at area scores, the differences between three institutions are emphasized: RCFs are
particularly underdeveloped in areas 1, 6 and 7 (governance, AEs management and
learning from experience) where they struggle to reach the setup stage, while LHAs are
behind the hospitals in areas 5 and 7 (care processes and learning from experience)
where they fail to reach the outcome stage. These scoring differences among three
organization types reflect the highest maturity level CRM reached in more complex
institutions like hospitals, while RCFs underdevelopment in areas 1 (including
resources invested, monitoring system and benchmarking strategies) and 7 (including
event analysis and peer assessments) is not unexpected as these areas reflect a more
awareness and CRM involvement.
Limitations
The self-evaluation tool’s main limitation is subjectivity; even if the single standards are
formulated clearly, there is room for interpretation or simply for different perceptions.
Also, as the questionnaire covers several structural and organizational areas, more than
one person can be involved (introducing even more subjectivity) or, if not, the single
compiler may not correctly perceive how every single thing works inside the organization.
Lastly, filling in a questionnaire (52 articulated standards) can be time consuming,
especially if discussion with other staff members is needed for some standards.
Conclusions and recommendations
The European Commission report on implementing council patient safety
recommendations, published in November 2012 (European Commission, 2012),
highlighted priorities areas on which future work should focus raising the need to
introduce, beyond the recommendations, clear and shared safety standards, considered
also an indispensable condition for EU citizens as mobile patients (European Union,
2011). Adopting CARMINA in healthcare organizations can be useful for fulfilling these
requirements as a starting point for achieving minimum CRM levels and as a
benchmarking tool. At the same time, healthcare CRM is generally evaluated as a
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broader approach based on quality assessment and verified through accreditation
processes. An inadequate CRM program (e.g. either safety indicators are not
implemented or do not reach acceptable levels) plays a fundamental role the entire
organization assessment (Accreditation Canada, 2013; Joint Commission International,
2013), making CARMINA helpful as an instrument for monitoring improvement on
recognized standards over time. As CARMINA was conceived as a monitoring
instrument, it needs to be regularly updated and expanded over time. First, a scoring
system upgrade to include all the objective criteria is needed: the Delphi weighted score
assigned for minimum levels will represent each standard’s half score, while the other
half sums the remaining objective criteria. Second, as CRM is a fast evolving field, the
tool needs to be kept fresh with emerging issues and policy initiatives. Third, as the
risks inherent in using a self-reported evaluation tool for institutional monitoring are
obvious, adding a proof mechanism (e.g. protocols, reports and improvement actions
documentation) has been contemplated as the tool’s first upgrade. Fourth, the tool was
inspired by European recommendations that call for common safety standards across
the union, but was developed for Italian healthcare services (with some standards
strictly connected to Italian ministerial initiatives). Nevertheless, its core can easily be
expanded and adapted for other countries. Finally, the tools need to be tested for
reliability (e.g. Cronbach’s α, test-retest study).
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